Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PALI | AZN | AMGN | GILD | VRTX |
| Company | Palisade Bio Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7700 | 72.52 | 289.44 | 105.33 | 500.79 |
| High | 0.7865 | 72.57 | 290.99 | 105.65 | 506.03 |
| Low | 0.7400 | 71.30 | 286.09 | 103.80 | 497.34 |
| Last | 0.7699 | 71.43 | 287.68 | 104.50 | 505.08 |
| Change | +0.0143 | -0.28 | -0.88 | +0.29 | +1.58 |
| % Change | +1.89% | -0.39% | -0.30% | +0.28% | +0.31% |
| Volume | 21,869 | 1,258,427 | 570,779 | 2,436,751 | 289,516 |
| 20-Day Average Volume | 41,703 | 6,988,794 | 3,066,372 | 9,659,660 | 1,627,014 |
| Previous Close | 0.7556 | 71.71 | 288.56 | 104.21 | 503.50 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.7076 | 68.47 | 286.89 | 105.64 | 487.70 |
| 20-Day Raw Stochastic | 73.68% | 71.92% | 43.20% | 52.20% | 96.40% |
| 20-Day Relative Strength | 44.80% | 52.95% | 46.94% | 46.91% | 57.82% |
| Weighted Alpha | -86.44 | -6.16 | -8.38 | +55.56 | +23.49 |
| Today's Opinion | 80% Sell | 24% Sell | 56% Sell | 40% Buy | 64% Buy |
| Previous Opinion | 80% Sell | 24% Sell | 40% Sell | 40% Buy | 56% Buy |
| Last Month's Opinion | 100% Sell | 8% Buy | 32% Buy | 100% Buy | 64% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.58% since 04/23/25 | +4.57% since 04/23/25 | +3.61% since 04/23/25 | -1.74% since 04/23/25 | +2.52% since 04/23/25 |
| Low | 0.6900 on 04/25/25 | 68.48 on 04/24/25 | 274.42 on 04/24/25 | 93.37 on 04/25/25 | 484.50 on 04/25/25 |
| High | 0.7900 on 04/30/25 | 72.57 on 04/30/25 | 290.76 on 04/30/25 | 107.56 on 04/24/25 | 506.96 on 04/29/25 |
| 1-Month | |||||
| %Chg | +7.45% since 03/28/25 | -2.91% since 03/28/25 | -6.20% since 03/28/25 | -6.49% since 03/28/25 | +2.47% since 03/28/25 |
| Low | 0.6000 on 04/04/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 93.37 on 04/25/25 | 448.14 on 04/07/25 |
| High | 0.7900 on 04/30/25 | 75.70 on 04/03/25 | 315.00 on 03/31/25 | 114.75 on 04/03/25 | 506.96 on 04/29/25 |
| 3-Month | |||||
| %Chg | -48.25% since 01/30/25 | +0.56% since 01/30/25 | +1.37% since 01/30/25 | +7.82% since 01/30/25 | +15.16% since 01/30/25 |
| Low | 0.6000 on 04/04/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 93.37 on 04/25/25 | 446.00 on 02/12/25 |
| High | 1.4300 on 01/31/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | -76.13% since 10/30/24 | -1.63% since 10/30/24 | -8.75% since 10/30/24 | +18.39% since 10/30/24 | +6.26% since 10/30/24 |
| Low | 0.6000 on 04/04/25 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 86.08 on 11/19/24 | 377.85 on 12/19/24 |
| High | 3.3000 on 12/12/24 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,322 | 222,390,416 | 155,144,576 | 129,758,432 | 129,440,280 |
| Shares Outstanding, K | 4,397 | 3,101,247 | 537,651 | 1,245,163 | 257,081 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -14,440,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 14,891,000,000 | 9,086,000,000 | 6,667,000,000 | 2,912,000,000 |
| Last Quarter Net Income | -3,340,000 | 1,499,000,000 | 627,000,000 | 1,315,000,000 | 913,000,000 |
| 60-Month Beta | 1.50 | 0.49 | 0.59 | 0.32 | 0.50 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.69 on 03/24/25 | 2.49 on 04/29/25 | 5.31 on 02/04/25 | 1.81 on 04/24/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 05/12/25 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 06/13/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.01 | 14.28 | 13.74 | 0.00 |